Loading…
AI investor
A data-grounded assistant: it reads a company’s fundamentals, valuation and earnings and lays out the bull and bear case.
Screens well
AbbVie Inc. is growing revenue +10% a year at a +10% net margin, and trades on 16.0× forward earnings. Analysts rate it “buy” and it generates $16.87B of free cash flow. Overall it screens as a quality business at a reasonable price.